Molecular Basis of Stepwise Cyclic Tetra-adenylate Cleavage by the Type III CRISPR Ring Nuclease Crn1/Sso2081
Overview
Authors
Affiliations
The cyclic oligoadenylates (cOAs) act as second messengers of the type III CRISPR immunity system through activating the auxiliary nucleases for indiscriminate RNA degradation. The cOA-degrading nucleases (ring nucleases) provide an 'off-switch' regulation of the signaling, thereby preventing cell dormancy or cell death. Here, we describe the crystal structures of the founding member of CRISPR-associated ring nuclease 1 (Crn1) Sso2081 from Saccharolobus solfataricus, alone, bound to phosphate ions or cA4 in both pre-cleavage and cleavage intermediate states. These structures together with biochemical characterizations establish the molecular basis of cA4 recognition and catalysis by Sso2081. The conformational changes in the C-terminal helical insert upon the binding of phosphate ions or cA4 reveal a gate-locking mechanism for ligand binding. The critical residues and motifs identified in this study provide a new insight to distinguish between cOA-degrading and -nondegrading CARF domain-containing proteins.
The SAVED domain of the type III CRISPR protease CalpL is a ring nuclease.
Binder S, Schneberger N, Schmitz M, Engeser M, Geyer M, Rouillon C Nucleic Acids Res. 2024; 52(17):10520-10532.
PMID: 39166476 PMC: 11417357. DOI: 10.1093/nar/gkae676.
Structural insight into the Csx1-Crn2 fusion self-limiting ribonuclease of type III CRISPR system.
Zhang D, Du L, Gao H, Yuan C, Lin Z Nucleic Acids Res. 2024; 52(14):8419-8430.
PMID: 38967023 PMC: 11317161. DOI: 10.1093/nar/gkae569.
Du L, Zhu Q, Lin Z EMBO J. 2024; 43(2):304-315.
PMID: 38177499 PMC: 10897365. DOI: 10.1038/s44318-023-00017-w.